Virender is a world-renowned ophthalmologist with expertise in cornea, anterior segment and uveitis. He has graduated in medicine from Maharshi Dayanand University in 1986 and completed his specialisation in ophthalmology in 1991. His career as ophthalmologist includes positions of fellowship on cornea and anterior segment surgery and of director at the prestigious L.V. Prasad, as well as a fellowship on ocular immunology and uveitis at the Massachusetts Eye and Ear. He is currently director of Innovation at the Dr. Shroff’s Charity Eye Hospital in Delhi, India.
Dr. Sangwan is well known for his research on corneal limbal stem cells, most prominently developing a method of growing cornea stem cells on amniotic membrane for subsequent implantation in human eyes for repairing injured cornea epithelium, which is reported to have been performed over 800 times at the LVPEI with a 76% success rate. His research was awarded by a number of prices including the prestigious Shanti Swarup Bhatnagar Prize for Science and Technology in 2006, the National Technology award for stem cell technology in 2007 and the Sunpharma Award for clinical research in 2015.
Current role
Scientific Advisor And Co-founder at Transformative
Managing Partner & Senior Scientific Advisor at Brookline Capital Markets
Chair of the Scientific Advisory Board at Therini Bio, Inc.
Scientific Advisor at zPREDICTA
Co-Founder and Scientific Advisor at Amorphology, Inc
Access the worlds's biggest network of public org charts
Learn more